School of Medicine
Showing 1-10 of 17 Results
-
Hua Tang
Professor of Genetics and, by courtesy, of Statistics
Current Research and Scholarly InterestsDevelop statistical and computational methods for population genomics analyses; modeling human evolutionary history; genetic association studies in admixed populations.
-
Jean Y. Tang MD PhD
Professor of Dermatology
On Partial Leave from 10/07/2024 To 10/06/2025Current Research and Scholarly InterestsMy research focuses on 2 main areas:
1. Skin cancer:
- New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
- Genomic analysis of drug-resistant cancers
- Identifying risk factors for skin cancer in the Women's Health Initiative
2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB -
Sami Gamal-Eldin Tantawi
Professor of Particle Physics and Astrophysics, Emeritus
BioFor over a decade I have advocated for dedicated research efforts on the basic physics of room temperature high gradient structures and new initiatives for the associated RF systems. This required demanding multidisciplinary collaboration to harness limited resources. The basic elements of the research needed to be inclusive to address not only the fundamentals of accelerator structures but also the fundamentals of associated technologies such as RF manipulation and novel microwave power sources. These basic research efforts were not bundled with specific developments for an application or a general program. The emerging technologies promise a broad, transformational impact.
With this underlying philosophy in mind, in 2006 the US High Gradient Research Collaboration for which I am the spokesman was formed. SLAC is the host of this collaboration, which comprises MIT, ANL, University of Maryland and University of Colorado, NRL and a host of SBIR companies. This led to the revitalization of this research area worldwide. The international collaborative effort grew to include KEK in Japan, INFN, Frascati in Italy, the Cockcroft Institute in the UK, and the CLIC team at CERN.
This effort led to a new understanding of the geometrical effects affecting high gradient operations. The collaborative work led to new advances in understanding the gradient limits of photonic band gap structures. Now we have a new optimization methodology for accelerator structure geometries and ongoing research on alternate and novel materials. These efforts doubled the usable gradient in normal conducting high gradient linacs to more than 100 MV/m, thus revitalizing the spread of the technology to other applications including compact Inverse Compton Scattering gamma-ray sources for national security applications, and compact proton linacs for cancer therapy. -
Melinda L. Telli, M.D.
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsMy research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.
-
Nelson Teng
Professor of Obstetrics and Gynecology (Oncology), Emeritus
Current Research and Scholarly InterestsGynecologic Malignancies
Immunotherapy
Biologic Response Modifiers
New Drug Development
Antigenic specificities of human antibodies encoded by the VH4-34 gene -
Avnesh Thakor
Associate Professor of Radiology (Pediatric Radiology)
Current Research and Scholarly InterestsInterventional Radiologists can access almost any part of the human body without the need for conventional open surgical techniques. As such, they are poised to change the way patients can be treated, given they can locally deliver drug, gene, cell and cell-free therapies directly to affected organs using image-guided endovascular, percutaneous, endoluminal, and even using device implantation approaches
-
Reena Thomas, MD PhD
Clinical Professor, Neurology & Neurological Sciences
Clinical Associate Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly Interests-Neuro Oncology Immunotherapy
-Medical Education -
Candice N. Thompson, MD
Clinical Assistant Professor, Surgery - General Surgery
Masters Student in Epidemiology and Clinical Research, admitted Autumn 2023BioDr. Thompson is a board-certified, fellowship-trained general surgeon who specializes in breast surgical oncology. She is a clinical assistant professor of surgery at Stanford University School of Medicine and the Medical Director for the Office of Cancer Health Equity.
Dr. Thompson clinical interests include treatment of women and men who have breast cancer, benign breast disease, genetic mutations, family history of breast cancer, or other breast cancer risk factors. Procedures performed by Dr. Thompson include lumpectomies (partial mastectomies) using oncoplastic techniques and hidden scar methods, skin- and nipple-sparing mastectomies, simple mastectomies with aesthetically flat closure, oncoplastic procedures, benign breast lesion excisions, axillary node dissections, and sentinel lymph node biopsies.
She completed a breast surgical oncology fellowship at Stanford University under the mentorship of one of the world’s foremost experts in the field. She completed her general surgery training at Georgetown University, where she was the co-administrative chief resident. She is passionate about equitable care and addressing healthcare disparities, especially in breast cancer.
Dr. Thompson works closely with medical oncology, radiation oncology, plastic surgery, genetics, and other breast cancer specialists in a multidisciplinary setting to provide high quality, evidence-based, and individualized care. Dr. Thompson is a strong advocate for patient education and empowerment and strives to deliver compassionate care to patients and their families.
Her research has focused on Nipple Sparing Mastectomies, Community Engagement for Breast Cancer in the Black Community, Immune responses during breast cancer treatment, and prognostic role of Circulating Tumor DNA (ctDNA) in the management of breast cancer. She also has strong research interests in community engagement, health disparities, oncoplastic surgical options, and cancer biomarkers. She has delivered presentations on a wide range of topics related to breast cancer at national and regional meetings including NRG Oncology, ASBrS, ASC.
For her scholarship and research achievements, Dr. Thompson has won numerous honors and awards. She has earned the resident teaching award during her chief year at Georgetown. She was awarded the Stanford Cancer Institute Clinical Innovation Fund Grant for her work in educating the Black Community about Breast Health and Breast Cancer (2022). She was also awarded the prestigious NCI Early-Surgeon Scientist Program (ESSP) Award to support her early career as a surgeon scientist(2024). She also serves on the AAS Academic Advancement Committee, NRG Oncology Surgical Oncology Committee, NCCN Breast Screening and Diagnosis Panel, and TOUCH Black Breast Advisor for Pink Table Talk.
Dr. Thompson is a member of the American College of Surgeons (ACS), American Society of Breast Surgeons (ASBrS), Society of Surgical Oncology (SSO), Society of Black Academic Surgeons (SBAS), Association of Women Surgeons (AWS), National Comprehensive Cancer Network® (NCCN®), and American Medical Association (AMA).
Outside of work, Dr. Thompson enjoys pilates, tennis, baking, sewing, wine tasting, and traveling.